Oncogene associated with human cancers and methods of use thereof
US9874565B2 · kind B2 · utility
0Cited by
1References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 23, 2014 |
| Grant date | Jan 23, 2018 |
| Priority date | — |
| Expiry date | Jun 23, 2034 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/4703
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention provides methods of treating cancer by inhibiting MECP2 and identifying cancers that will respond to therapy using MECP2 as a biomarker.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.